Search by Keyword |
NN ProEPA
Nordic Naturals EPA, one of the industry’s highest concentrations of EPA from fish, is enhanced with natural lemon oil in both the soft gel capsule and oil for great lemon taste. EPA is molecularly distilled for purity and concentration, and has added rosemary extract for superior freshness. This high concentrate formula provides excellent nutritional support for the body to manufacture vital series 3 prostaglandins, and is “repeat” and “odor free.” Suggested Use: Two soft gels daily, with food, or as directed by your health care professional or pharmacist. General Nutrient Support: Cardiovascular disease may be the most common cause of death in the United States. Symptoms often associated with cardiovascular disease may include high LDL “bad” cholesterol levels, high blood pressure, and overall poor circulation. EPA (Eicosapentaenoic) is a polyunsaturated fatty acid and a precursor to the anti-inflammatory prostaglandin series 3. Much of the interest surrounding omega-3 fatty acids arose from the discovery that Greenland Inuit and coastal Japanese populations consume high levels of omega-3 fatty acids and have remarkably healthy cardiovascular systems. Since then, extensive research on omega-3 fatty acids from fish indicates that several different mechanisms of action are responsible for their possible heart healthy benefits. The omega-3 fatty acids, EPA and DHA, play important structural roles as components of cellular membranes. Ongoing clinical studies support the role of EPA and omega-3 fatty acids in health and disease. Ingredients: purified deep sea fish oil (from anchovies and sardines), soft gel capsule (gelatin, water, glycerin, natural lemon oil), natural lemon oil, d-alpha tocopherol, rosemary extract Two 1000 mg Soft Gels Contain: EPA: 850 mg DHA: 200 mg Other Omega-3s: 180 mg Vitamin E: 30 IU There is mounting evidence that low levels of n-3 polyunsaturated fatty acids (PUFAs) play a role in the pathophysiology of a number of psychiatric disorders. Preclinical studies have shown that n-3 PUFAs decrease anxiety-like behaviors, but there is a paucity of information about their effects on anxiety in humans. In light of our observation that substance abusers have poor dietary habits and of the strong association between anxiety disorders and substance use disorders, the possibility that the administration of supplements of n-3 PUFAs would decrease the anxiety level of a group of substance abusers was explored. Thirteen patients were given, on a daily basis, capsules containing 3 g of n-3 PUFAS (EPA+DHA). Eleven patients received similar-looking placebo capsules containing vegetable oil. The trial was double-blind, randomized, and lasted 3 months. A scale assessing anxiety feelings was administered at baseline and on a monthly basis thereafter. Six PUFA group patients and 8 placebo group patients were followed for an additional 3 months after treatment discontinuation and administered the same questionnaire monthly. Patients who received n-3 PUFAs for 3 months showed a progressive decline in anxiety scores. This was not the case for patients who received placebos. A comparison of the 2 groups was significant (p=.010). Anxiety scores remained significantly decreased in the PUFA group for 3 months following treatment discontinuation. A comparison of the 2 groups followed for 6 months was also significant (p=.042). In conclusion, these preliminary data indicate that n-3 PUFA supplementation could be beneficial in the treatment of some patients with anxiety disorders. The product used in this study was purchased from Nordic Naturals. The product name was ProEPA™/EPA™. The dose used was 5 capsules. |
|
|||||||||||||||||||||||||||
 contact@ethicalsupplements.com |
|||||||||||||||||||||||||||||
